The multiple sclerosis PRISMS study:: Prevention of relapses and disability by interferon β-1a subcutaneously in multiple sclerosis

被引：0
|
作者：
Ebers, GC
Oger, J
Paty, D
Li, D
Freedman, M
Hartung, HP
Hommes, O
McLeod, J
Sandberg, M
Wikström, J
Carton, H
Hughes, RAC
Pancelius, M
Medaer, R
Blumhardt, L
Barnes, D
Bertelsmann, F
Chofflon, M
Kappos, L
King, J
Newsom-Davis, J
Sindic, C
Uitehaag, B
Van Doom, P
Bates, D
Dupont, F
Galazka, A
Hyde, R
Pernin, MO
Abdul-Ahad, A
机构：
来源：
ANNALS OF NEUROLOGY | 1997年 / 42卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
2
引用
收藏
页码：986 / 986
页数：1
相关论文
共 50 条
  • [1] Efficacy of subcutaneous interferon β-1a in patients with early-stage multiple sclerosis enrolled in the Prevention of Relapses and Disability by Interferon B-1a Subcutaneously in Multiple Sclerosis study: results of a post hoc analysis
    Coyle, P.
    Singer, B.
    Cohen, B.
    Bennett, R.
    Al-Sabbagh, A.
    [J]. MULTIPLE SCLEROSIS, 2009, 15 (09): : S236 - S236
  • [2] Associations between annualized relapse rate and long-term exposure to subcutaneous interferon β-1a in the Prevention of Relapses and disability by Interferon β-1a Subcutaneously in Multiple Sclerosis (PRISMS) long-term follow-up study
    Uitdehaag, B.
    Constantinescu, C.
    Cornelisse, P.
    Jeffery, D.
    Kappos, L.
    Li, D.
    Sandberg-Wollheim, M.
    Traboulsee, A.
    Verdun, E.
    Rivera, V.
    [J]. JOURNAL OF NEUROLOGY, 2010, 257 : S148 - S148
  • [3] The PRISMS study.: Interferon-β 1a (Rebif®) in intermittent multiple sclerosis
    Hartung, HP
    Flachenecker, P
    Weilbach, FX
    Rieckmann, P
    [J]. NERVENARZT, 1999, 70 (02): : 182 - 185
  • [4] Interferon-beta 1a subcutaneously and multiple sclerosis:: experience in an MS unit
    Romero-Pinel, L
    Alonso-Magdalena, L
    Moral, E
    Carmona, O
    Casado, V
    Martínez-Yélamos, S
    Arbizu, T
    [J]. JOURNAL OF NEUROLOGY, 2005, 252 : 63 - 63
  • [5] Contribution of relapses to disability in multiple sclerosis
    C. Hirst
    G. Ingram
    O. Pearson
    T. Pickersgill
    N. Scolding
    N. Robertson
    [J]. Journal of Neurology, 2008, 255 : 280 - 287
  • [6] Relapses in multiple sclerosis: Relationship to disability
    Goodin, Douglas S.
    Reder, Anthony T.
    Bermel, Robert A.
    Cutter, Gary R.
    Fox, Robert J.
    John, Gareth R.
    Lublin, Fred D.
    Lucchinetti, Claudia F.
    Miller, Aaron E.
    Pelletier, Daniel
    Racke, Michael K.
    Trapp, Bruce D.
    Vartanian, Timothy
    Waubant, Emmanuelle
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2016, 6 : 10 - 20
  • [7] Contribution of relapses to disability in multiple sclerosis
    Hirst, Claire
    Ingram, Gillian
    Pearson, Owen
    Pickersgill, Trevor
    Scolding, Neil
    Robertson, Neil
    [J]. JOURNAL OF NEUROLOGY, 2008, 255 (02) : 280 - 287
  • [8] Interferon-β1a for the treatment of multiple sclerosis
    Clerico, Marinella
    Contessa, Giulia
    Durelli, Luca
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2007, 7 (04) : 535 - 542
  • [9] Interferon β-1a and Atorvastatin in the Treatment of Multiple Sclerosis
    Ghasami, Keyvan
    Faraji, Fardin
    Fazeli, Masoud
    Ghazavi, Ali
    Mosayebi, Ghasem
    [J]. IRANIAN JOURNAL OF IMMUNOLOGY, 2016, 13 (01) : 16 - 26
  • [10] Relapses and progression of disability in multiple sclerosis.
    Confavreux, C
    Vukusic, S
    Moreau, T
    Adeleine, P
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (20): : 1430 - 1438
12345